196 related articles for article (PubMed ID: 2317817)
1. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice.
Tanaka Y; Eda H; Tanaka T; Udagawa T; Ishikawa T; Horii I; Ishitsuka H; Kataoka T; Taguchi T
Cancer Res; 1990 Apr; 50(8):2290-5. PubMed ID: 2317817
[TBL] [Abstract][Full Text] [Related]
2. Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma.
Matsumoto T; Fujimoto-Ouchi K; Tamura S; Tanaka Y; Ishitsuka H
Br J Cancer; 1999 Feb; 79(5-6):764-9. PubMed ID: 10070867
[TBL] [Abstract][Full Text] [Related]
3. Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice.
Tanaka K; Urata N; Mikami M; Ogasawara M; Matsunaga T; Terashima N; Suzuki H
Inflamm Res; 2007 Jan; 56(1):17-23. PubMed ID: 17334666
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals.
Bibby MC; Double JA; Ali SA; Fearon KC; Brennan RA; Tisdale MJ
J Natl Cancer Inst; 1987 Mar; 78(3):539-46. PubMed ID: 3546909
[TBL] [Abstract][Full Text] [Related]
5. Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice.
Beck SA; Tisdale MJ
Cancer Res; 1989 Jul; 49(14):3800-4. PubMed ID: 2736521
[TBL] [Abstract][Full Text] [Related]
6. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host.
Beck SA; Tisdale MJ
Cancer Res; 1987 Nov; 47(22):5919-23. PubMed ID: 3311359
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with those with early transplants.
Tanaka Y; Tanaka T; Ishitsuka H
Cancer Res; 1989 Nov; 49(21):5935-9. PubMed ID: 2790809
[TBL] [Abstract][Full Text] [Related]
8. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.
Joppa MA; Gogas KR; Foster AC; Markison S
Peptides; 2007 Mar; 28(3):636-42. PubMed ID: 17204351
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model.
Tisdale MJ; Dhesi JK
Cancer Res; 1990 Aug; 50(16):5022-6. PubMed ID: 2379167
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine.
Kanzaki M; Soda K; Gin PT; Kai T; Konishi F; Kawakami M
Cytokine; 2005 Dec; 32(5):234-9. PubMed ID: 16338141
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice.
Yasumoto K; Mukaida N; Harada A; Kuno K; Akiyama M; Nakashima E; Fujioka N; Mai M; Kasahara T; Fujimoto-Ouchi K
Cancer Res; 1995 Feb; 55(4):921-7. PubMed ID: 7850809
[TBL] [Abstract][Full Text] [Related]
12. Protein synthesis measured in vivo in muscle and liver of cachectic tumor-bearing mice.
Emery PW; Lovell L; Rennie MJ
Cancer Res; 1984 Jul; 44(7):2779-84. PubMed ID: 6722806
[TBL] [Abstract][Full Text] [Related]
13. [Role of NF-kappa B in cancer cachexia].
Zhou W; Jiang ZW; Jiang J; Li N; Li JS
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
[TBL] [Abstract][Full Text] [Related]
14. Relationship between tumor growth and cachexia during progressive malignant disease: a new measure of the extent of cachexia, the cachexia index.
Bassukas ID; Maurer-Schultze B
Anticancer Res; 1991; 11(3):1237-41. PubMed ID: 1888155
[TBL] [Abstract][Full Text] [Related]
15. Effects of tumor type and burden on carcass lipid depletion in mice.
Hollander DM; Ebert EC; Roberts AI; Devereux DF
Surgery; 1986 Aug; 100(2):292-7. PubMed ID: 3738756
[TBL] [Abstract][Full Text] [Related]
16. Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
Graves E; Hitt A; Pariza MW; Cook ME; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):48-55. PubMed ID: 15625711
[TBL] [Abstract][Full Text] [Related]
17. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.
Strassmann G; Fong M; Freter CE; Windsor S; D'Alessandro F; Nordan RP
J Clin Invest; 1993 Nov; 92(5):2152-9. PubMed ID: 8227330
[TBL] [Abstract][Full Text] [Related]
18. Anticachectic activity of 5'-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma.
Tanaka Y; Eda H; Fujimoto K; Tanaka T; Ishikawa T; Ishitsuka H
Cancer Res; 1990 Aug; 50(15):4528-32. PubMed ID: 1695121
[TBL] [Abstract][Full Text] [Related]
19. Comparison of animal models for head and neck cancer cachexia.
Cannon T; Couch M; Yin X; Guttridge D; Lai V; Shores C
Laryngoscope; 2007 Dec; 117(12):2152-8. PubMed ID: 17921906
[TBL] [Abstract][Full Text] [Related]
20. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.
Kawamura I; Lacey E; Yamamoto N; Sakai F; Takeshita S; Inami M; Nishigaki F; Naoe Y; Tsujimoto S; Manda T; Shimomura K; Goto T
Anticancer Res; 1999; 19(5B):4105-11. PubMed ID: 10628361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
